AORT Stock Analysis: Buy, Sell, or Hold?
AORT - Artivion, Inc.
$20.68
0.55 (2.73%)
▲
5d:
-1.85%
30d:
-9.18%
90d:
-42.11%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When AORT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: AORT shows positive signals but monitor for confirmation. Market pricing in 9.0% decline. Moderate conviction.
💡 BUY OPPORTUNITY: AORT shows positive signals but monitor for confirmation. Market pricing in 9.0% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$35.05
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$21.76
5.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AORT is currently trading at $20.68, which is considered slightly low relative to its 30-day fair value range of $20.37 to $22.54. From a valuation perspective, the stock is trading at a discount (Forward PE: 28.7) compared to its historical average (38.2). Remarkably, the market is currently pricing in an annual earnings decline of 9.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, AORT is in a strong downtrend. Immediate support is located at $19.88, while resistance sits at $22.12.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Implied Volatility is high (100th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $42.00 (+103.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AORT is in a strong downtrend. Immediate support is located at $19.88, while resistance sits at $22.12.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Implied Volatility is high (100th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $42.00 (+103.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$20.37 -
$22.54
Company Quality Score
57/100
(HOLD)
Options IV Signal
100th percentile
(EVENT RISK)
Volume Confirmation
HIGH
Confidence Score
64.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Options expensive (IV 100th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 103.1% below Wall St target ($42.00)
Trading Range Analysis
30-Day Trading Range
$20.37 -
$22.54
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$3.56
(17.2%)
Support & Resistance Levels
Support Level
$19.88
Resistance Level
$22.12
Current Trend
Strong Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
28.72
Wall Street Target
$42.00
(+103.1%)
Revenue Growth (YoY)
17.5%
Profit Margin
2.5%
Valuation Discount vs History
-9.0% cheaper
PE vs Historical
28.7 vs 38.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.0%
(market-implied from PE analysis)
1-Year Target
$18.82
(-9%)
2-Year Target
$17.13
(-17%)
3-Year Target
$15.58
(-25%)
3-Yr Target (if PE normalizes)
(PE: 29→38)
$20.73
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 28.7, Growth: 63.0%)
$69.79
(+238%)
Base:
(SPY PE: 21.8, Growth: 63.0%)
$52.93
(+156%)
Bear:
(PE: 18.5, Growth: 63.0%)
$44.99
(+118%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (82x PE), but valuation improves significantly next year (29x PE) as earnings recover.
Trailing PE: 81.82 | Current EPS (TTM): $0.25
Bull Case
$45.00
(+118%)
Analyst growth 100.0%, PE expands to 90.0
Base Case
$40.91
(+98%)
Market implied 100.0%, PE stable at 81.8
Bear Case
$13.91
(-33%)
Severe decline -20.0%, PE contracts to 69.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 28.7 to 38.2
Stabilization Target:
$27.50
(+33.0%)
PE Expansion Potential:
+33.0%
Share & Embed Analysis
Last updated: June 24, 2026 8:34 AM ET
Data refreshes hourly during market hours. Next update: 9:34 AM
Data refreshes hourly during market hours. Next update: 9:34 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AORT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Jean F Holloway
SELL
8962 shares
2026-03-04
Marshall S Stanton
SELL
2149 shares
2026-03-03
Lance A Berry
SELL
6316 shares
2026-03-03
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 60 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 61 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 61 BUY |
Advanced AORT Option Strategies
Professional options setups generated by AI based on today's AORT price and gamma walls.
